Skip to main content
SpringerLink
Log in

Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A/B and EZH2 in lesional psoriatic skins

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Psoriasis is a chronic, non-infectious skin disease affects 2–3% of the population worldwide. In order to find genes possibly cause this skin disease, we re-analyzed the gene expression data-sets from three published studies. We compared the gene expression profiles between lesional psoriatic skin (PP), uninvolved psoriatic skin (PN) and normal skin (NN) tissues. We found that compared with in PN and NN tissues, the expression of FOXO1 is significantly repressed and the expression of AURKA, AURKB and EZH2 is significantly up-regulated in PP tissues (P < 0.001). During the treatment of psoriasis patients with TNF-α antagonist Etanercept, the expression of FOXO1 was re-activated and the expression of AURKA and EZH2 was repressed. These results suggest loss of FOXO1 expression and elevated AURKA/B and EZH2 expression in lesional psoriatic tissues have potential contribution to the development of psoriasis. It is worthwhile to test whether the combination of Aurora kinases or EZH2 inhibitors can enhance the therapeutic effects of Etanercept in psoriasis management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509

    Article  PubMed  CAS  Google Scholar 

  2. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699–711

    Article  PubMed  CAS  Google Scholar 

  3. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappa B pathways. Nat Genet 41:199–204

    Article  PubMed  CAS  Google Scholar 

  4. Bhalerao J, Bowcock AM (1998) The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 7:1537–1545

    Article  PubMed  CAS  Google Scholar 

  5. Kunz M (2008) DNA microarray technology in dermatology. Semin Cutan Med Surg 27:16–24

    Article  PubMed  CAS  Google Scholar 

  6. Gudjonsson JE, Ding J, Li X, Nair RP, Tejasvi T, Qin ZS et al (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129:2795–2804

    Article  PubMed  CAS  Google Scholar 

  7. Yao Y, Richman L, Morehouse C, de Los Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener PA, Jallal B (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS One 3:e2737

    Article  PubMed  Google Scholar 

  8. Zaba LC, Suárez-Fariñas M, Fuentes-Duculan J, Nograles KE, Guttman-Yassky E, Cardinale I, Lowes MA, Krueger JG (2009) Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol 124:1022–1030

    Article  PubMed  CAS  Google Scholar 

  9. Li C, Wong WH (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98:31–36

    Article  PubMed  CAS  Google Scholar 

  10. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics (Oxford, England) 18:207–208

    Article  CAS  Google Scholar 

  11. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K (2004) S100 proteins in the epidermis. J Invest Dermatol 123:23–33

    Article  PubMed  CAS  Google Scholar 

  12. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115:2382–2392

    Article  PubMed  CAS  Google Scholar 

  13. Furuyama T, Kitayama K, Shimoda Y, Ogawa M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S, Nakayama K, Nakayama K, Ikeda K, Motoyama N, Mori N (2004) Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 279:34741–34749

    Article  PubMed  CAS  Google Scholar 

  14. Chua RA, Arbiser JL (2009) The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity 42:574–579

    Article  PubMed  CAS  Google Scholar 

  15. Carmena M, Earnshaw WC (2003) The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4:842–854

    Article  PubMed  CAS  Google Scholar 

  16. Dutertre S, Descamps S, Prigent P (2002) On the role of aurora-A in centrosome function. Oncogene 21:6175–6183

    Article  PubMed  CAS  Google Scholar 

  17. Adams RR, Carmena M, Earnshaw WC (2001) Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 11:49–54

    Article  PubMed  CAS  Google Scholar 

  18. Sparmann A, van Lohuizen M (2006) Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6:846–856

    Article  PubMed  CAS  Google Scholar 

  19. Simon JA, Kingston RE (2009) Mechanisms of polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10:697–708

    PubMed  CAS  Google Scholar 

  20. Campos EI, Reinberg D (2009) Histones: annotating chromatin. Annu Rev Genet 43:559–599

    Article  PubMed  CAS  Google Scholar 

  21. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM et al (2006) Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125:301–313

    Article  PubMed  CAS  Google Scholar 

  22. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40:499–507

    Article  PubMed  CAS  Google Scholar 

  23. Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G et al (2009) Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 136:1122–1135

    Article  PubMed  CAS  Google Scholar 

  24. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L et al (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369–375

    Article  PubMed  CAS  Google Scholar 

  25. Galindo MP, Bartlett BL, Gewirtzman A, Mendoza N, Tremaine AM, Tyring SK (2008) Etanercept: an overview of its role in the treatment of psoriasis. Expert Opin Drug Metab Toxicol 4:305–310

    Article  PubMed  CAS  Google Scholar 

  26. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58:826–850

    Article  PubMed  Google Scholar 

  27. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 58:851–864

    Article  PubMed  Google Scholar 

  28. Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JM, Miller KM (2004) VX-680, a potent and selective small-molecule inhibitor of the aurora kinases, suppresses tumor growth in vivo. Nat Med 10:262–267

    Article  PubMed  CAS  Google Scholar 

  29. Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL, Karuturi RK, Tan PB, Liu ET, Yu Q (2007) Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev 21:1050–1063

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Masonic Cancer Center, University of Minnesota, 5-156 MCB, 420 Washington Ave, SE, Minneapolis, MN, 55455, USA

    Shuai Chen

  2. Department of Dermatology, Zhuzhou No. 1 Hospital, Zhuzhou City, 412000, Hunan Province, P. R. China

    Yayan Liu & Wenhui Luo

Authors
  1. Yayan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenhui Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuai Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuai Chen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (XLS 243 kb)

Supplementary material 2 (XLS 181 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Y., Luo, W. & Chen, S. Comparison of gene expression profiles reveals aberrant expression of FOXO1, Aurora A/B and EZH2 in lesional psoriatic skins. Mol Biol Rep 38, 4219–4224 (2011). https://doi.org/10.1007/s11033-010-0544-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-010-0544-x

Keywords

Search

Navigation